ALX ONCOLOGY HOLDINGS INC Share Price Today: Live Updates & Key Insights
ALX ONCOLOGY HOLDINGS INC share price today is $2.07, up 0.5%. The stock opened at $1.97 against the previous close of $2.02, with an intraday high of $2.075 and low of $1.97.
ALX ONCOLOGY HOLDINGS INC Share Price Chart
ALX ONCOLOGY HOLDINGS INC
ALX ONCOLOGY HOLDINGS INC Share Price Performance
ALX ONCOLOGY HOLDINGS INC Institutional Holdings
ALX ONCOLOGY HOLDINGS INC Market Status
ALX ONCOLOGY HOLDINGS INC Fundamentals
Market Cap 271.82 M
PB Ratio 1.8093
PE Ratio 0.0
Enterprise Value 140.01 M
Total Assets 59.05 M
Volume 1011372
ALX ONCOLOGY HOLDINGS INC Company Financials
About ALX ONCOLOGY HOLDINGS INC & investment objective
Company Information ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company's lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has collaboration agreement for Evorpacept combination programs comprising Jazz Pharmaceuticals plc for zanidatamab, under phase 1b/2 trial for the treatment of breast cancer and other solid tumors; HER2 with an ADC, fam-trastuzumab deruxtecan-nxki, under phase 1 trial for the treatment of patients with breast cancer; ALX2004, under phase 1 clinical trial for treating solid tumors; MD Anderson Cancer Center with rituximab and lenalidomide for the treatment of patients with indolent and aggressive NHL; and Sanofi with isatuximab and dexamethasone, under phase 1/2 trial for the treatment of patients with relapsed or refractory multiple myeloma. It has license agreements with Board of Trustees of Leland Stanford Junior University. The company was incorporated in 2015 and is headquartered in South San Francisco, California.
Organisation Biotechnology
Employees 43
Industry Biotechnology
CEO Mr. Jason W. Lettmann
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ALX ONCOLOGY HOLDINGS INC FAQs
What is the share price of ALX ONCOLOGY HOLDINGS INC today?
The current share price of ALX ONCOLOGY HOLDINGS INC is $2.07.
Can I buy ALX ONCOLOGY HOLDINGS INC shares in India?
Yes, Indian investors can buy ALX ONCOLOGY HOLDINGS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy ALX ONCOLOGY HOLDINGS INC shares in India?
You can easily invest in ALX ONCOLOGY HOLDINGS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ALX ONCOLOGY HOLDINGS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ALX ONCOLOGY HOLDINGS INC.
Can I buy fractional shares of ALX ONCOLOGY HOLDINGS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ALX ONCOLOGY HOLDINGS INC?
ALX ONCOLOGY HOLDINGS INC has a market cap of $271.82 M.
In which sector does ALX ONCOLOGY HOLDINGS INC belong?
ALX ONCOLOGY HOLDINGS INC operates in the Biotechnology sector.
What documents are required to invest in ALX ONCOLOGY HOLDINGS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of ALX ONCOLOGY HOLDINGS INC?
The PE ratio of ALX ONCOLOGY HOLDINGS INC is N/A and the PB ratio is 1.81.